Publication | Open Access
Efficacy of combination therapy of fluvoxamine and favipiravir vs favipiravir monotherapy to prevent severe COVID-19 among mild to moderate COVID-19 patients: Open-label randomized controlled trial (EFFaCo study)
17
Citations
17
References
2023
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1